Form 4: Ventyx Biosciences CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO Raju Mohan sold 4,312 shares of Ventyx Biosciences stock to cover tax obligations related to vesting restricted stock units.
Summary
- On April 2, 2024, Raju Mohan, CEO and President of Ventyx Biosciences, sold 4,312 shares of common stock.
- The sale was executed to satisfy tax withholding obligations related to the vesting of restricted stock units.
- The shares were sold at a weighted average price of $5.4034, with individual prices ranging from $5.2736 to $5.4062.
- Following the transaction, Mohan directly owns 1,578,250 shares of Ventyx Biosciences.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (selling shares to cover taxes) and doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into insider transactions, allowing investors to monitor the actions of company executives and directors.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 04/02/2024 | Date of transaction: CEO Raju Mohan sold shares. |
| 04/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.